HSBC Holdings plc (NYSE: HSBC) — An Asia-Anchored Deposit Machine Re-Rated From Half Book to Full Price

Independent equity research. All figures USD unless stated; HSBC reports in US dollars under IFRS, fiscal year = calendar year. HSBC is a US ADR: 1 ADS = 5 ordinary shares (LSE: HSBA.L / HKEX: 0005.HK). As-of date 2026-07-10; ADR $99.09.

⚡ Claude’s Take

This block is the author’s own subjective opinion and general information only — not investment advice and not a recommendation to buy or sell any security. The analysis that follows is deliberately position-free and carries no price target; this block is the single exception.

Verdict: HOLD / accumulate-on-weakness. A genuinely better bank than the market remembered — an Asia-anchored, ~17%-ex-notables-RoTE deposit-and-transaction-banking machine — that has already been re-rated from a war-discount ~0.6x tangible book to a full ~2.05x. The plan worked; the price now reflects it. Fresh capital belongs in the ~$77–85 ADR zone (≈1.6–1.75x tangible book, near the 200-day line), not at ~$99 (≈2.05x TBV / ~15.5x earnings) after a +66% year and the richest price-to-book in the stock’s traded history (99th percentile of its own range).

HSBC’s story is no longer the sprawling, sub-cost-of-capital “global bank going nowhere” of the 2010s. Under CEO Georges Elhedery (since September 2024), the group has amputated the low-return Western franchises (Canada sold to RBC, US mass retail and France retail exited, Argentina gone, Indonesia/Malta/South Africa/Sri Lanka retail sold), collapsed the matrix into four accountable units split “Eastern” and “Western,” and doubled down on where it actually earns money: Hong Kong / Asia (the $13.7bn Hang Seng privatization is the statement of intent), global transaction banking (the genuinely wide-moat trade-finance and payments network — #1 trade bank in the world), and Asia wealth (net new money $39bn in Q1-26, $34bn of it Asian; $1.6tn of balances). Q1-2026 RoTE ex-notables printed 18.7% — the highest in nearly twenty years — and management has committed to 17%+ RoTE every year through 2028 with a 50% dividend payout and rolling buybacks. This is a real, delivered improvement, and the ~3x move off the 2020 low was earned.

The catch is the same one that caught Barclays: the market has noticed. At ~2.05x tangible book on ~15.5x earnings, HSBC already prices a durable mid-teens RoTE at a compressed ~9–10% cost of equity — i.e., it credits the 2028 target as achieved and permanent, and pays nearly twice Standard Chartered’s ~1.1x multiple for a similar Asia footprint at a lower reported RoTE. But the returns are softer than the headline: reported FY2025 RoTE was 13.3%, not the 17.2% ex-notables figure, and a meaningful slice of even that is rate-peak-flattered (HIBOR ~2.5%, Fed/HKMA peg, a still-reinvesting structural hedge) and one-off-flattered (Hang Seng minority removal). The honest through-the-cycle number is more likely low-teens — genuinely good for a universal bank, but not 17–18%. And the buyback that powered the re-rating is now spent as a value lever: above ~2x tangible book, repurchases dilute rather than accrete TNAV/share. Against that, you are underwriting the single most concentrated geopolitical bet in large-cap banking: ~50%+ of group profit from Hong Kong and Asia, a balance sheet wedged between Washington and Beijing, and a largest shareholder (Ping An) that has openly agitated to break the company in two. Framing: a re-rated, high-quality, low-beta quality-momentum name — the exact opposite of a falling knife (beta ~0.84, +66% trailing year, near all-time highs), and therefore priced for delivery, not for disappointment. Tag: “You’ve stopped buying a discount to book and started buying a premium to a rate peak.”

Conviction: medium. The single fact that flips me more bullish: RoTE holding ≥16% through a full Fed/HKMA/BoE rate-cutting cycle, proving the returns are structural (Asia wealth + transaction banking) rather than a NIM peak — that would justify paying up toward 2x TBV. The single fact that flips me bearish: a China/Hong Kong shock (CRE, capital controls, a forced Asia breakup, or US-China sanctions crossfire) or RoTE reverting toward ~12% as rates normalize — either re-opens a geopolitical discount toward 1.1–1.3x TBV, and at 1.8x the downside is real.

📈 Stock Price Action — Five-Year Event Map

Factual price history, not a recommendation. Price moves are FACT; attributed causes are INTERPRETATION. No price target, no support/resistance. USD ADR closes (unadjusted); 1 ADS = 5 ordinary shares.

The arc. The HSBC ADR round-tripped from a COVID-era low of ~$18.11 (25 September 2020) — the trough of a decade of “dead money,” a cancelled 2020 dividend, Hong Kong-protest and US-China anxiety — to $99.09 (10 July 2026), a ~5.5x move that has essentially carried the stock back to its October-2007 all-time-high zone (~$99.5): a nineteen-year round trip to par. The ADR is at a fresh multi-decade high, ~0% off its 52-week peak; the trailing-52-week range is $61.30 (July 2025) → $99.09 (July 2026), and the shares trade above their 21-, 50- and 200-day EMAs ($95.1 / $92.7 / $81.6). Beta is ~0.84 with positive alpha, and the trailing-12-month return is +66% — a low-beta, high-dividend franchise behaving like a momentum leader.

Cycle narrative. (1) The recovery off the September-2020 low is the reversal of HSBC’s worst period — the regulator-forced 2020 dividend cancellation, Hong Kong unrest, and US-China friction — as payouts resumed and Asia reopened. (2–3) 2022 is a two-sided year: a first-half rate-hike rally to ~$38 (higher rates lift a deposit-rich bank’s NII) that fully unwound to ~$25 by October as China’s zero-COVID lockdowns, the property-developer crisis, and Ping An’s campaign to break up the Asia business collided. (4) The China-reopening pivot in December 2022, plus the restart of dividends-and-buybacks and a reputation-enhancing £1 rescue of SVB UK, drove a ~48% recovery into early 2023. (5) 2023–24 is the capital-return-and-simplification chapter: shareholders rejected Ping An’s spin-off push (May-23), management sold HSBC Canada to RBC for ~$10.1bn and returned a $0.21 special dividend, and new CEO Georges Elhedery launched the “Eastern/Western” reorganisation. (6) 2025 is the re-rating proper — a “mid-teens RoTE” target, relentless buybacks, and Asian earnings resilience lifted the ADR ~47%. (7) The 2026 leg to a fresh high is delivery: FY2025 results printed a 17.2% ex-notables RoTE and raised the return ambition to 17%+, pushing the ADR back to a price it last saw at the 2007 peak. The stock now trades on delivery and momentum, at the richest price-to-book in its own history — not on a discount.

1. Executive Summary

HSBC Holdings plc is a ~$3.23 trillion-balance-sheet global universal bank, incorporated and prudentially regulated in the United Kingdom but earning the majority of its profit in Asia — above all in Hong Kong. It is best understood not as one bank but as a portfolio of franchises bound by a global wholesale-payments network: two crown-jewel national scale banks (Hong Kong, UK), one genuinely world-class global business (Corporate & Institutional Banking, anchored by the #1-ranked trade-finance and transaction-banking network), and a fast-growing, capital-light Asia wealth franchise (International Wealth & Premier Banking). FY2025 group revenue was $68.3bn reported ($71.0bn constant-currency ex-notables), reported profit before tax $29.9bn, and reported return on tangible equity 13.3% — 17.2% excluding a recurring ~$6.7bn of “notable items.” Hong Kong alone contributed 28.2% of group profit; Asia in aggregate is well over half.

The investable event of the last two years is a self-help re-rating. Under CEO Georges Elhedery (September 2024), HSBC collapsed a bloated three-segment matrix into four accountable units on an “Eastern/Western” axis, targeted ~$1.5bn of cost savings, and pruned its sub-scale Western footprint — selling Canada to RBC (~$10bn, a $4.8bn gain and a special dividend), exiting the US mass-market, Argentina, France retail, and putting Malta, Indonesia retail and reportedly Turkey up for sale — while doubling down on Asia via the $13.7bn privatisation of Hang Seng Bank. Returns followed: ex-notables RoTE rose to 17.2% in FY2025 and an annualised 18.7% in Q1-2026 (the highest print in nearly two decades), management raised its return ambition to 17%+ every year through 2028, ~17% of the share count has been retired, and capital returns run ~$19bn a year on a fortress 14.9% CET1. The ADR has compounded ~5.5x off its September-2020 low of ~$18 to $99.09 — back to its 2007 all-time-high zone.

The catch is valuation. On HSBC’s own reported tangible net asset value (~$9.6/ordinary, ~$48/ADR — a figure that correctly deducts ~$20bn of AT1), the ADR trades at ~2.05x tangible book and ~15.5x reported earnings — the richest price-to-book in the stock’s traded history (P/B 99th percentile, P/S 99.9th of its own multi-year range), and nearly twice the ~1.1x multiple of Standard Chartered, its truest Asia peer, which posted a higher reported RoTE (14.7%). Embedded-expectations analysis implies the market is capitalising a durable ~15% RoTE at a compressed ~9–10% cost of equity — i.e., it credits the 2028 ambition as achieved and permanent. Two facts temper that: the ex-notables RoTE strips out restructuring, legal and associate charges that have recurred for years, and the underlying returns are meaningfully rate-peak-flattered as the Fed/HKMA-peg and Bank of England ease. The dominant risk is not solvency — capital and liquidity are ample — but geopolitical concentration: a bank with ~50%+ of its profit in Greater China, wedged between Washington and Beijing, with a Chinese insurer (Ping An) as its largest shareholder having openly pressed to break it up.

Verdict in brief: a genuinely higher-quality, better-run bank than the 2010s conglomerate — two real moats (the Hong Kong deposit franchise and the global transaction-banking network), disciplined capital returns, and improving earnings composition toward capital-light Asia wealth. But the price has caught up to, and arguably slightly through, the fundamentals: the margin of safety of the sub-book era is gone, the buyback’s value-accretion is spent above 2x tangible book, and the durable return is probably low-teens rather than the 17% the multiple pays for. This report takes no position and sets no price target; it lays out the embedded expectations and the falsification tests for each side. (The one deliberately-labeled opinion, Claude’s Take, appears above.)

2. Business Overview

HSBC Holdings plc is a ~$3.23 trillion-balance-sheet global universal bank, dual-anchored in Hong Kong and the United Kingdom, that describes itself as “the world’s leading international bank.” Founded in Hong Kong and Shanghai in 1865 to finance Sino-European trade, HSBC today serves ~40 million customers across roughly 58 markets, reports in US dollars under IFRS, and — as a UK-incorporated foreign private issuer — files a 20-F and 6-Ks rather than 10-Ks. It is not, in truth, one bank but a portfolio of national and cross-border banking franchises stitched together by a common brand and a genuinely global wholesale-payments network — a structure that is simultaneously the source of its one irreplicable moat (transaction banking) and of its perennial “conglomerate discount” problem. (FACT: HSBC Annual Results 2025; company profile.)

The 2025 reorganisation is the lens through which the business must now be read. Effective 1 January 2025, under CEO Georges Elhedery (appointed September 2024), HSBC collapsed its legacy three-segment structure (WPB / CMB / GBM) and its geographic matrix into four businesses, grouped along an “Eastern markets vs. Western markets” axis: Hong Kong; the UK; Corporate & Institutional Banking (CIB) — the merged wholesale bank (ex-Global Banking & Markets plus international commercial banking); and International Wealth & Premier Banking (IWPB) — the cross-border affluent/wealth franchise. The redesign is not cosmetic: it walls off the two crown-jewel scale banks (Hong Kong, UK) as standalone reporting units, concentrates the genuinely global business (CIB) in one place, and exposes each to a divisional return target. (FACT: HSBC completes next phase of global restructure, hsbc.com, 2024–2025.)

How HSBC makes money — and where. The FY2025 divisional table is the single most important exhibit for understanding the franchise:

*Profit share = share of reported PBT; Hong Kong reported PBT was $8.6bn (+17%). FY25 group reported PBT $29.9bn; ex-notables constant-currency PBT $36.6bn. (Source: HSBC Annual Results 2025 quick read; media release 25-Feb-2026. FACT for revenue and profit-share; segment PBT figures approximate from disclosed profit shares.)

Two structural facts jump out. First, this is an Asia-weighted bank wearing a London head office. Hong Kong alone generated 28.2% of group profit off 22% of revenue — the highest-return large unit — and if one adds the Eastern-markets share of CIB and IWPB, well over half of group profit originates in Asia, the bulk of it in Hong Kong. (INTERPRETATION, grounded in the profit-share disclosure.) Second, the profit engine is CIB, at 34.8% of profit, and within CIB the durable, high-return core is wholesale transaction banking (trade finance, cash management, FX, payments) rather than the cyclical markets/advisory book — a distinction that matters enormously for earnings quality.

The revenue mix is a barbell of annuity and cycle. Roughly two-thirds of group revenue is net interest income — the spread on a ~$1.7 trillion deposit base, much of it low-cost Hong Kong and UK current-account money — supplemented by a UK/Western structural hedge; this is stable, rate-sensitive, and annuity-like. The remaining third is fee and other income, of which the fastest-growing and highest-quality slice is wealth (IWPB and Hong Kong wealth fees of $9.4bn, up 24% in 2025) and transaction-banking fees (CIB generated $13.1bn of fee/other income). The lower-quality, genuinely cyclical slice is markets trading and investment-banking fees inside CIB. (FACT: HSBC 2025 results.) Management’s 2026–28 framing leans hard on the annuity components: a RoTE ex-notables target of “mid-teens / 17% or better each year,” banking NII of “around $46bn” in 2026, mid-single-digit revenue growth to ~5% by 2028, and a 50% dividend payout — i.e., a bank trying to be valued on recurring wealth and transaction income, not on trading. (FACT: HSBC 2025 targets; hypothesis, not evidence — validate against outcomes.)

Recurring vs. cyclical, and the notable-items problem. HSBC’s reported earnings are unusually noisy for a bank of its quality: the ~$6.7bn gap between reported PBT ($29.9bn) and ex-notables PBT ($36.6bn) in 2025 came from a $2.1bn Bank of Communications (BoCom) associate dilution/impairment, a $1.5bn reserve-recycling loss on the completed sale of the French home-loan portfolio, $1.4bn of legal provisions, and $1.0bn of restructuring. (FACT: HSBC 2025 results; wealthbriefing, 26-Feb-2026.) This is the analytical trap: reported RoTE of 13.3% understates the underlying franchise, while ex-notables RoTE of 17.2% is the number management wants anchored — the truth is that a bank which repeatedly generates $5–7bn of “notable” charges from disposals, associates and restructuring is telling you something about the cost of running a sprawling, geopolitically-exposed empire, and those items should not simply be waved away as one-offs. (INTERPRETATION.)

Verdict. HSBC is a genuinely high-quality, deposit-rich, Asia-centred universal bank with one world-class global business (transaction banking / trade finance) bolted onto two strong national scale banks (Hong Kong, UK) and a growing cross-border wealth franchise — a materially better business than a UK-only peer like Barclays. But it remains a conglomerate: the same breadth that produces the transaction-banking moat also produces perpetual restructuring, disposal losses, associate write-downs and a governance/geopolitical overhang that keep reported returns well below the flattering ex-notables headline. The 2025 reorganisation sharpens the disclosure and the focus; it does not change the fundamental identity of a business whose quality is real but whose complexity is a permanent tax.

3. Industry Dynamics

HSBC competes in at least four structurally distinct industries, and the cardinal analytical error is to average them. They must be judged separately.

(a) Hong Kong / Asia banking — structurally excellent. This is the best industry HSBC touches, and it is why the stock has re-rated. Hong Kong retail and commercial banking is a tight, regulated oligopoly: HSBC (via The Hongkong and Shanghai Banking Corporation) is one of only three note-issuing banks in the territory (alongside Standard Chartered Hong Kong and Bank of China (Hong Kong)), issues the largest share of Hong Kong’s banknotes, and — together with newly-privatised subsidiary Hang Seng Bank — commands the dominant deposit franchise in the city. (FACT: HKMA; HSBC 2025 results.) Barriers to entry are extreme (licensing, the note-issuing privilege, a century of relationship capital, branch density), switching costs are high, and the deposit base is enormous, low-cost and sticky — HSBC’s Hong Kong unit ran a 43.2% cost-efficiency ratio (1H25), far better than the group, precisely because it is a scale deposit-gatherer rather than a cost-heavy trading house. (FACT: HSBC interim data pack.) Structurally, the unit also sits astride two of the most powerful secular flows in global finance: Asian (especially Chinese) wealth creation — driving the 24% growth in group wealth fees — and Hong Kong’s role as the offshore-RMB and mainland-connectivity hub (Stock/Bond Connect, cross-boundary Wealth Management Connect in the Greater Bay Area). The Hang Seng take-private is itself a Marathon-style favourable capital-cycle signal: HSBC is deploying ~$14bn to consolidate an oligopoly it already dominates rather than to chase growth in a competitive market.

(b) UK ring-fenced retail/commercial banking — a good oligopoly. HSBC UK is one of Britain’s “big five” ring-fenced banks (with Lloyds, NatWest, Barclays UK, Santander UK), which collectively control roughly three-quarters of UK current accounts. The same structure that benefits Barclays applies: high entry barriers, low switching, a legally ring-fenced deposit-funded balance sheet, and a multi-year structural-hedge and higher-base-rate tailwind — powerful into 2026–27 but, by construction, sector-wide and receding as the Bank of England cuts and legacy hedges reinvest. (INTERPRETATION, consistent with a prior analysis of Barclays.) UK returns (~21% profit share on ~18% of revenue) are solid but not differentiated: this is a shared, pro-incumbent oligopoly, not a proprietary advantage, and it is exposed to UK macro, motor-finance conduct redress, and the bank surcharge/levy.

© Global transaction banking / trade finance — HSBC’s genuine scale industry, and structurally attractive for the leader. This is the industry that distinguishes HSBC from every UK and most global peers. Trade finance, cross-border cash management and payments are network industries with strong economies of scale and demand-side captivity: value rises with the number of markets, correspondent relationships and currencies a bank can offer, and corporate treasurers, once integrated, face high switching costs. HSBC is the world’s #1 trade-finance bank for the eighth consecutive year (Euromoney Trade Finance Survey 2025, 13,000+ corporate votes), operates in 50+ markets, facilitated $857bn of cross-border commerce, and was named Euromoney’s World’s Best Bank for Large Corporates 2025. (FACT: euromoney.com 2025.) For the scaled leader this is a high-return, capital-light, fee-and-float business with a real moat; for a subscale competitor it is unattractive — which is exactly why the industry consolidates around a handful of global networks (HSBC, Citi, JPMorgan, Standard Chartered, BNP Paribas). In Marathon terms, the supply side here is disciplined and favours incumbents.

(d) Global markets & investment banking — structurally mediocre for a non-US, mid-tier player. The markets/advisory slice inside CIB competes in a wallet dominated by the US bulge bracket (JPMorgan, Goldman, Morgan Stanley, BofA, Citi). It is capital-hungry, cyclical, and offers weak pricing power to anyone outside the top tier. HSBC is a respectable but marginal participant, and management has tacitly conceded the point by winding down M&A/ECM in Western markets under the reorganisation — retreating from the industry where it lacks scale to double down where it has it. (FACT: HSBC restructuring disclosures 2024–2025; INTERPRETATION on competitive standing.)

The rate and regulatory environment. HSBC is doubly exposed: the Hong Kong dollar’s peg to the US dollar ties Hong Kong NII to the Fed’s rate path, while the UK book tracks the Bank of England — so HSBC faces two central-bank easing cycles compressing NIM into 2026–27, partly cushioned by deposit stickiness and the structural hedge. Banking NII guidance of “around $46bn” for 2026 is the key swing number. (FACT: HSBC 2025.) On regulation, HSBC is dual-regulated (PRA/FCA in the UK, HKMA in Hong Kong) and subject to Basel 3.1, UK ring-fencing, and — uniquely and materially — the geopolitical crossfire between the US/UK and China, including Hong Kong national-security-law exposure and the risk of secondary sanctions. This is a genuine, non-diversifiable industry risk that peers headquartered wholly in one bloc do not carry to the same degree.

Verdict. A split decision. Hong Kong/Asia banking is a structurally excellent oligopoly (note-issuance, deposit captivity, wealth flows, China connectivity); global transaction banking/trade finance is structurally attractive for the scaled leader, which HSBC is; UK retail is a good, shared oligopoly; and global markets/IB is structurally mediocre for a mid-tier non-US player. The blended industry position is above-average and improving, because HSBC is deliberately reallocating capital toward its two best industries (Asia deposits/wealth, global transaction banking) and away from its worst (Western markets/IB). The one industry-level fact no reallocation can fix is geopolitics: HSBC’s best market, Hong Kong, is also its single largest structural risk.

4. Competitive Position

HSBC has two genuine, nameable moats and a lot of no-moat sprawl around them. The investment question is whether the two moats are strong enough to lift group returns durably above the cost of equity — or whether they are perpetually diluted back to mediocrity by the conglomerate they subsidise.

Moat 1 — the Hong Kong scale/deposit/note-issuance franchise (Greenwald: economies of scale + demand captivity). In one city, HSBC has all three of the advantages Greenwald recognises as real. It has economies of scale (the largest branch, deposit and clearing footprint in Hong Kong, now enlarged by the Hang Seng take-private); demand-side captivity (sticky retail and commercial relationships, salary accounts, mortgage relationships, and the habit-and-trust premium of a 160-year incumbent); and a regulatory quasi-franchise (one of three note-issuing banks, a privilege that is both a marketing asset and a signal of systemic primacy). This shows up unambiguously in the numbers: the Hong Kong unit is the group’s highest-returning large business (28.2% of profit on 22% of revenue, 43.2% cost-efficiency), and it funds itself with cheap, abundant deposits. This is a durable, financially-evident moat — exactly the kind that would deteriorate if it disappeared. The caveat is that it is geographically concentrated in a single, geopolitically fraught city, which caps the multiple the market will pay for it.

Moat 2 — the global transaction-banking / trade-finance network (Greenwald: economies of scale + switching costs). This is HSBC’s strongest and most irreplicable advantage, and the one no UK peer possesses. A correspondent-banking and trade-finance network spanning 50+ markets, multiple currencies and decades of counterparty relationships is a classic increasing-returns network: it cannot be built quickly, cannot be bought cheaply, and gets more valuable as it gets larger (every added market makes the bank more useful to every multinational client). Eight straight years as Euromoney’s #1 trade-finance bank, $857bn of cross-border commerce facilitated, and the World’s Best Bank for Large Corporates 2025 award are external validation that this is a genuine leadership position, not a marketing claim. (FACT: euromoney.com 2025.) Corporate-treasury switching costs (integrated cash-management, ERP connections, multi-country credit lines) reinforce it. This moat shows up as the high-quality, recurring fee income inside CIB’s $13.1bn fee base — the annuity that management is trying to get the market to capitalise.

Where there is no moat — say so. The markets/IB slice of CIB is subscale versus the US bulge bracket, commoditised, cyclical, and capital-hungry — no durable advantage, which is why HSBC is shrinking Western-markets IB. The UK retail franchise has a real but shared oligopoly moat identical to Lloyds’ and NatWest’s — captivity without differentiation; HSBC cannot out-earn UK-only peers domestically. IWPB in Western markets (Europe, Americas) is a subscale, no-advantage affluent-banking business that HSBC has been actively exiting (US mass retail, Canada, France, Argentina). The recurring pattern of the last decade — sell Canada to RBC, exit US retail, sell France retail, exit Argentina, reportedly sell Turkey to Emirates NBD — is the tacit admission that outside Asia and global transaction banking, HSBC largely lacks a competitive advantage and is right to retreat. (FACT: HSBC disposals 2023–2026; INTERPRETATION on moat absence.)

The pressure test: is the network a real moat, or is HSBC a low-RoTE conglomerate? For a decade the honest answer was “a low-RoTE conglomerate with two good assets” — group RoTE sat in the single digits to low teens, dragged by trapped capital in low-return Western units, associate drag (BoCom), and a bloated matrix. The 2025 evidence is more favourable but not conclusive: ex-notables RoTE reached 17.2%, which is genuinely peer-competitive, and all four businesses cleared mid-teens RoTE ex-notables. But reported RoTE was 13.3%, the ~$6.7bn notable-items gap recurs year after year, and reported cost-efficiency actually deteriorated to ~53% (from ~51% in 2024). The moats are real; the question is whether Elhedery’s simplification permanently narrows the reported-vs-underlying gap or whether the empire keeps generating “notable” leakage. (INTERPRETATION.)

Direct peer comparison (FY2025) locates HSBC precisely:

(Sources: company FY2025 results; Barclays FY2025 results. FACT.)

The table tells the story. On reported RoTE (13.3%), HSBC sits mid-pack — better than Barclays and Lloyds, below NatWest, DBS and JPMorgan. On ex-notables RoTE (17.2%), it looks like a top-quartile bank, roughly level with DBS and above Standard Chartered. Against its truest structural comparators — DBS and Standard Chartered, the other Asia-network banks — HSBC is more efficient than Standard Chartered (~53% vs ~63% cost:income) but materially less efficient than DBS (~40%), the cleaner, Singapore-focused compounder that carries no Western-conglomerate baggage. The gap to DBS is the quantified cost of HSBC’s sprawl. Meanwhile HSBC out-earns the IB-diluted UK universals (Barclays, and Lloyds ex-motor) precisely because its Asia deposit/wealth franchise and global transaction bank are better businesses than a subscale UK investment bank.

Verdict. HSBC possesses two genuine, financially-evident moats — the Hong Kong scale/deposit/note-issuing franchise and the global transaction-banking/trade-finance network — that are stronger and more durable than anything Barclays or Lloyds owns, and that place it in the same conversation as DBS and Standard Chartered rather than the UK universals. But it is not a clean compounder: the moats are surrounded by no-moat markets/IB and subscale Western units, the reported-vs-ex-notables gap is a recurring symptom of conglomerate complexity, and the whole edifice sits on a single geopolitically-exposed city for its highest returns. The competitive position is genuinely good and improving as management concentrates capital on the two moats and retreats from the rest — but the market is right to withhold a DBS/JPMorgan-quality multiple until the reported returns, not just the adjusted ones, prove the simplification has stuck.

5. Growth History and Forward Opportunities

HSBC is not a growth company and should not be valued as one; it is a rate- and capital-cyclical universal bank whose reported “growth” blends structural-hedge/rate income, Asia wealth fees, share-count shrinkage, and a large layer of disposal noise that flatters or depresses the headline year to year. The task is to separate the durable, capital-light element (Asia wealth) from the borrowed, rate-cycle element (banking net interest income) and from the accounting distortions (disposal gains and losses).

Revenue and profit history (USD, IFRS). Reported revenue was $68.3bn in FY2025 (+4%), and on a constant-currency, ex-notable-items basis $71.0bn (+$3.4bn). Reported profit before tax was $29.9bn in FY2025, down ~7% from $32.3bn in FY2024 — but the reported line is badly distorted by notable items in both years. On the cleaner constant-currency, ex-notable basis, PBT rose $2.4bn to $36.6bn (HSBC FY2025 media release, 25 Feb 2026). The multi-year reported-PBT path — ~$17.1bn (2022) → ~$30.3bn (2023, flattered by the Silicon Valley Bank UK bargain-purchase and provisional Canada gains) → $32.3bn (2024, flattered by the Canada disposal gain) → $29.9bn (2025) — is a saw-tooth of disposal accounting, not a compounding curve. The tell is per-share: EPS was $6.39/ADR in FY2025, actually down from $6.53 in FY2024, because FY2024 carried the Canada-sale gains while FY2025 absorbed ~$1.7bn of disposal/reserve-recycling losses (France retail, UK life) even as the underlying franchise improved (HSBC AR 2025). (Fact.) Reported RoTE was 13.3% (vs 14.6% FY24); ex-notable RoTE was 17.2%, up 1.6pp — the number management runs the bank against.

Where the growth is high-quality: Asia wealth (IWPB). This is the real engine and the strategic centre of gravity. IWPB revenue was $14.5bn in FY2025 (+5% CC), but the quality is in the fee line: bank-wide wealth fee and other income reached $9.4bn, +24% constant-currency, delivering the “double-digit” ambition twice over (HSBC AR 2025). The bank attracted $80bn of net new invested assets in FY2025, $39bn of it in Asia; wealth balances stood at $2.1tn at year-end, of which >$1.2tn is booked in Asia — HSBC is the leading wealth manager in Asia and the Middle East (finews.asia; hubbis.com, Feb 2026). Singapore wealth invested assets passed $100bn for the first time with fee income +27%; Premier 3.0 is live in seven markets and 29 new Wealth Centres opened. This is genuinely high-quality growth: fee-based, capital-light (low RWA density, so it lifts RoTE without consuming CET1), recurring, and levered to a structural secular tailwind — rising Asian/Chinese/Gulf household wealth and cross-border flows through the Hong Kong and Singapore hubs. (Interpretation, grounded in the fee/NNIA facts.)

Where the growth is lower-quality: banking NII and transaction banking. Group net interest income was $34.8bn and banking NII $44.1bn (+$0.3bn), on a NIM of 1.59% (+3bps) — solid, but this is rate-cycle income that fades as the Bank of England, the Fed and (via the HKD peg) HKMA cut. Management guides banking NII to at least $45bn in 2026, implying only marginal growth and confirming the rate tailwind is plateauing (HSBC FY2025 media release). CIB — the largest profit contributor at 34.8% of group PBT, revenue $27.6bn (+3%) — grew principally through Wholesale Transaction Banking (payments, trade, FX, securities services): a genuinely sticky, deposit-and-flow franchise built on HSBC’s unmatched cross-border network, and higher-quality than the Western M&A/ECM activity being wound down. But transaction-banking revenue is itself part deposit-spread (rate-sensitive) and part fee.

Forward opportunities are evolutionary: (1) Asia/Gulf wealth compounding — the single most durable driver, targeting continued double-digit fee growth as invested assets and Premier penetration rise; (2) transaction banking / trade on the cross-border network, the clearest structural moat; (3) cost-out reinvestment — the Elhedery simplification frees capacity to redeploy into Asia; (4) the Google Cloud AI partnership (Jun 2026) for cost efficiency and hyper-personalised advice; against these, (5) a receding rate tailwind and shrinking Western footprint cap group revenue growth — management’s own medium-term target is revenue growth merely reaching 5% by 2028 (HSBC FY2025 media release).

Verdict: mixed-quality growth, improving in composition. The high-quality core — capital-light Asia wealth fees (+24%) and cross-border transaction banking — is real, secular, and RoTE-accretive, and is the best reason to own the franchise. But a large share of the reported five-year profit step-up was rate-cycle NII and one-off disposal accounting, and the per-share line went backwards in FY2025. The mix-shift toward fees is the genuinely positive trend; the reliance on a plateauing rate cycle and on buyback-driven per-share support is the caveat.

6. Financial Quality

Headline picture (USD, group, IFRS — HSBC’s own reported figures unless noted; per-ADR = ×5 ordinary):

(Sources: HSBC Annual Results 2025 media release, 25-Feb-2026; HSBC FY2025 Form 20-F; HSBC Q1-2026 release, 5-May-2026; ROIC.ai cross-check. Where ROIC and the filing differ, the filing governs. FACT unless labelled.)

Start with the headline that looks like bad news and isn’t. Reported EPS fell to $6.39/ADR in FY2025 from $6.53 in FY2024, and reported profit before tax fell $2.4bn to $29.9bn. Read naively, that is an earnings decline at a bank trading at its richest-ever multiple. It is the opposite. FY2024’s reported PBT was flattered by disposal gains as HSBC exited Canada (sold to RBC) and Argentina; FY2025’s reported PBT is depressed by roughly $4.5bn of notable-item drags — a $2.1bn BoCom dilution/impairment, $1.4bn of legal provisions, and $1.0bn of restructuring and related costs tied to CEO Georges Elhedery’s simplification programme (HSBC Annual Results 2025, 25-Feb-2026). Strip the noise and the underlying trajectory reverses: PBT ex-notables (constant-currency) rose to $36.6bn from $34.2bn, and RoTE excluding notable items climbed to 17.2% from 15.6% — clearing management’s “mid-teens or better” target. The reported-vs-clean gap of ~390bps of RoTE is the single most important quality-of-earnings adjustment in this memo, and it runs in HSBC’s favour on the trend, not against it. The buyback further cushions the optics: net income to ordinary shareholders fell 7.1% ($23.98bn → $22.29bn) but EPS fell only 2.1%, because ~17% of the share count has been retired over five years (20.63bn → 17.14bn ordinary shares).

The anchor return metric — and a denominator caveat. For a deposit-funded bank the return that matters is return on tangible common equity, and HSBC’s own figure is 13.3% reported / 17.2% ex-notables for FY2025 (HSBC 2025 media release). ROIC.ai’s return_com_eqy of 13.1% (FY2025) sits essentially on top of the reported RoTE — they agree because both measure earnings against common tangible equity, unlike a total-equity ROE which would sit lower. The honest reading is therefore: HSBC’s durable franchise return is somewhere between the reported 13.3% and the ex-notables 17.2%, because the “notable items” being added back — restructuring, legal provisions, a BoCom write-down — are recurring in character even if any single item is non-repeating. A bank that takes restructuring or conduct charges in most years should not be capitalised at its clean number. Interpretation: the defensible mid-cycle RoTE is high-teens at the peak and low-teens through the cycle — genuinely good for a universal bank, but not the 17–19% the ex-notables headlines advertise.

Net interest income is the swing factor, and it is rate-peak-flattered. Reported NII travelled $35.8bn (2023) → $32.7bn (2024, dragged by disposals and funding redeployed to the trading book) → $34.8bn (2025). Because that reported line is distorted by where funding costs are booked, HSBC guides investors instead on banking NII — the construct that adds back the internal cost of funding trading positions — which was $44.1bn in FY2025 and is guided to ~$46bn for FY2026 (raised from “at least $45bn” at Q1-26). NIM ticked up 3bps to 1.59%, HSBC attributing the gain to reinvesting the structural hedge at higher yields. This is the crux of the durability question. HSBC’s NII is levered to three rate regimes at once: US rates (via the Hong Kong dollar’s peg to the Fed, which drives HIBOR and the vast Hong Kong deposit franchise), UK/BoE rates, and the structural hedge. Q1-2026 already showed the sensitivity — banking NII fell $0.5bn sequentially on “day-count and lower HIBOR.” As the Fed and BoE cut, and HIBOR follows the peg down, the banking-NII tailwind that underwrites much of the 17%+ RoTE recedes. The returns are real but rate-cyclical; 2025–26 is closer to a cyclical high than a structural floor.

Cost, credit and capital — solid, with rising-but-contained credit. The reported cost efficiency ratio is ~53% (operating expenses $36.4bn on revenue $68.3bn), and management held target-basis cost growth to +3% while absorbing the reorganisation, guiding to ~1% growth in 2026 as the ~$1.5bn of annualised cost saves land — a credible operating-leverage story if delivered. The expected-credit-loss charge rose to $3.9bn / 39bps of average loans (from $3.5bn), concentrated in Hong Kong and mainland-China commercial real estate — a live, HSBC-specific credit sore that has run for three years. Q1-2026 credit was noisier still: a $1.3bn ECL / 52bps annualised, up $400m year-on-year on a UK fraud-linked financial-sponsor single-name and Middle-East-conflict provisioning, prompting HSBC to lift its FY2026 cost-of-risk guidance to ~45bps from ~40bps. This is not a solvency issue, but it is a reminder that the loan book carries recurring China-CRE and idiosyncratic single-name volatility. Capital is a fortress: CET1 held at 14.9% at FY2025 (flat year-on-year despite $6bn of 2025 buybacks and dividends), drifting to 14.0% at Q1-26 as the Hang Seng privatisation and RWA growth bit — still comfortably inside the 14.0–14.5% target range. On a $3.233 trillion balance sheet, that capital position and HSBC’s deep Asian deposit funding make the equity’s realistic downside an earnings-and-multiple compression, not an impairment of book.

The tangible-book reconciliation that matters for valuation. HSBC’s own reported TNAV is $9.22 per ordinary share ($46.1 per ADR) at FY2025, up from $8.61 (2024), $8.19 (2023) and a $7.44 trough (2022) — a steady ~24% cumulative rebuild driven by retained earnings and buybacks executed while the stock traded below book. Note the aggregator gotcha: ROIC.ai reports tangible book of $55.25/ADR — ~20% higher — because it does not deduct the ~$20bn of AT1 (additional Tier 1) instruments that sit in equity but are not attributable to ordinary shareholders. HSBC’s $9.22 figure, which does deduct AT1, is the correct base and the one on which peers’ P/TBV are also quoted. At the $99.09 ADR (10-Jul-2026), that is roughly 2.1x tangible book — richer than the ~1.8x a ROIC-derived TNAV would imply, and the single most important number for the valuation section to carry forward. A bank earning a rate-flattered high-teens ex-notables RoTE (low-teens clean) at ~2.1x tangible book is priced for the peak to persist.

Dividend and buyback — the capital-return engine, now on a shrinking discount. The FY2025 dividend of $0.75/ordinary ($3.75/ADR) is down from FY2024’s $0.87 — but only because 2024 carried a $0.21 special funded by the Canada sale; ex-special, the ordinary dividend rose ($0.66 → $0.75), consistent with the ~50% payout target. HSBC announced $6bn of buybacks in respect of 2025, below the ~$11bn-plus of the Canada-disposal-fuelled 2024 (total 2024 shareholder distributions reached $26.9bn). The buyback has been the highest-return capital lever available — retiring ~17% of shares over five years, much of it below tangible book, which mechanically accretes TNAV/share and lifts RoTE on a shrinking base. Interpretation: as with Barclays, that accretion fades precisely as the stock re-rates through book; at ~2.1x TBV, further repurchases are now dilutive to tangible book per share, so the most powerful value engine of the re-rating is losing potency.

Quality-of-earnings verdict — durable-good, but the headline returns are peak-flattered and add-back-inflated. Three things are genuinely high quality: the ~$3.2 trillion, Asia-anchored, deposit-rich funding base; the fortress capital (CET1 14.9%); and a disciplined cost and payout regime. Two things demand skepticism: (1) the 17.2%/18.7% ex-notables RoTE headlines strip out recurring-in-character restructuring, legal and BoCom charges and lean heavily on a rate-peak banking-NII tailwind that the HKMA-peg and BoE cuts will erode — the durable clean-and-through-cycle RoTE is more likely low-teens; and (2) the reported-EPS decline is a red herring (2024 disposal-gain-flattered, 2025 restructuring-drag-depressed) — underlying earnings power rose. Do economics improve with scale? Only modestly. HSBC’s scale delivers a low-cost Hong Kong/Asia deposit franchise and a genuine transaction-banking network — real advantages — but its group RoTE has for a decade been dragged, not lifted, by the sprawl the Elhedery reorganisation is now cutting. Returns here improve with the rate cycle, with disposals of subscale Western units, and with buybacks — not primarily with incremental scale. This is a good, well-capitalised bank whose reported returns currently sit at or above their sustainable ceiling.

7. Capital Allocation

Capital allocation is where the HSBC bull and bear cases collide most sharply. On the surface the story is exemplary — a bank returning ~$19–27bn a year, retiring a sixth of its share count, and pruning sub-scale Western geographies to concentrate on Asia and wealth. Look closer and the two largest capital decisions of the last two years point in opposite directions: a shareholder-friendly buyback whose value-accretion has quietly run out of road, and a $13.7bn acquisition of a troubled Hong Kong subsidiary that paused that very buyback.

Capital returns — large, but no longer a TNAV machine. HSBC’s distribution record is genuinely heavy: $19bn in respect of 2023, $26.9bn for 2024 (inflated by the Canada-sale special), and $18.9bn for 2025 — the latter comprising a $0.75/ordinary-share dividend and $6bn of buybacks (FACT — HSBC FY2025 results media release, 25 Feb 2026; HSBC “Annual Results 2025 quick read”). The board holds a ~50% dividend payout target (ex-notables) and has retired the ordinary share count from 20.6bn (2021) to ~17.2bn (17,201,971,220 shares as of 24 Oct 2025) — roughly 17% cancelled in four years (FACT — HSBC SEC 6-K own-share transaction notices). That is real per-share accretion. But the mechanism matters, and here HSBC differs materially from a Barclays. Barclays repurchased stock at 0.5–0.7x tangible book, the single highest-return lever a bank has — buying $1 of tangible equity for 60 cents. HSBC has been buying at or above tangible book throughout: the stock re-rated from ~1.0x TBV at end-2024 to ~1.4x at end-2025 (@ $78.67/ADR) to ~1.8x today (@ $99) (INTERPRETATION, from ROIC P/TBV series). Buying back at ≥1x tangible book is at best TNAV-neutral and at these levels modestly dilutive to tangible book per share — the buyback still supports EPS and signals confidence, but the powerful auto-accretion engine that flattered UK peers trading below book was never available to HSBC and is now firmly behind it. This is the central capital-allocation caveat: the trailing return machine looks better than the forward one.

*Includes a $0.21 special dividend from the Canada disposal. (FACT — HSBC results releases 2023–2025; CNBC 21 Feb 2024. Buybacks executed within calendar 2025 were higher (~$8bn) than the “$6bn in respect of 2025” figure; HSBC reports on an “in respect of” basis.)

Portfolio reshaping — the “shrink Western, double-down Eastern” strategy. The disposal programme is coherent in direction and mixed on execution. The Canada retail sale to RBC (~$10bn, closed March 2024) was the standout: a $4.8bn gain, a +0.7pp CET1 uplift, and the funding for the special dividend — a full-price exit of a sub-scale franchise (FACT — HSBC RNS 28 Mar 2024). Against that, Argentina was sold to Grupo Financiero Galicia for a $550m base consideration and a $1.0bn pre-tax loss — a value-destructive but defensible severing of a hyperinflationary, capital-trapped unit (FACT — Fortune, 9 Apr 2024; HSBC 20-F FY2024). The exits from US mass-market retail, France retail banking, French life insurance (to Matmut), and the reported early-stage sale of Turkey to Emirates NBD (Bloomberg, 30 Jun 2026) all fit the Marathon capital-cycle logic of withdrawing capital from low-return, contested Western markets. The July-2026 retreat from riskier private-credit lending — after a $400m charge tied to a UK financial-sponsor securitization exposure — is a belated but correct risk-off (FACT — Bloomberg/FT, 7 Jul 2026).

The Hang Seng privatisation is the decision to scrutinise. In October 2025 HSBC agreed to buy out the ~37% minority of Hang Seng Bank it did not own for $13.7bn — a 33% premium (HK$155 vs an undisturbed HK$116.5), a ~120bps CET1 hit, and a suspension of buybacks for roughly three quarters until CET1 returns to the 14.0–14.5% target range (FACT — HSBC press release, 9 Oct 2025; completed 26 Jan 2026). Management calls it “purely commercial.” The uncomfortable context: Hang Seng carries a 6.7% NPL ratio (its highest since 1999), ~36% of loans in Hong Kong commercial real estate, and a 1H25 ECL charge that tripled to HK$4.86bn (FACT — Bloomberg, Oct 2025). Interpretation: HSBC deployed $13.7bn of capital — above book, at a premium, into the epicentre of the Hong Kong CRE downturn, and interrupted its own shareholder returns to do it. The plausible read is less “opportunistic value” than taking full control to manage a problem child’s asset quality and integrate its balance sheet — a defensive, control-motivated deal dressed as growth. It is the antithesis of the disciplined, return-of-capital instinct the rest of the programme displays, and the single data point most at odds with the “great capital allocator” narrative.

Restructuring under Elhedery — credible so far. The October-2024 reorganisation into four units (UK, Hong Kong, CIB, IWPB) on an Eastern/Western axis targets ~$1.5bn of annualised cost saves for ~$1.8bn of one-off severance, with $1.2bn already stripped in 2025 and the full target now expected by mid-2026, six months early, alongside a ~15% net cut in managing-director roles (FACT — HSBC; Reuters/FStech 2025). Delivery ahead of plan and the removal of the long-criticised matrix are genuine positives; the risk is that cost-out is being partly offset by the revenue drag of a shrinking Western footprint.

Incentive alignment — well-designed on paper. The 2025 annual incentive is 60% financial (Group RoTE 25%, PBT 10%, fee-income-vs-balance-sheet growth 10%, target-basis opex 15%) and 30% strategic, all under a CET1 underpin; the 2026–28 LTI weights average RoTE (CET1 underpin) 42.5%, relative TSR 42.5%, environmental 15% (FACT — HSBC 2025 Directors’ Remuneration Report). RoTE and relative TSR dominating the scorecards is exactly what aligns management with per-share value rather than balance-sheet empire-building. Post the UK bonus-cap removal, fixed pay is being cut and the mix shifted toward variable (annual incentive max 215% of salary, LTI max 320%), with the CEO’s latest disclosed single-figure ~£5.4m/$6.8m (FACT — Bloomberg, 19 Feb 2025). Open question: whether the targets embedded in those weightings are stretching — HSBC does not disclose them prospectively.

Ping An overhang. The largest holder (~8%, ~$13bn) spent 2022–23 pressing for a spin-off / Hong Kong minority-listing of the Asia arm; the proposal was resoundingly rejected at the 2023 AGM, HSBC arguing it would cause “material erosion of earnings, returns, dividends and shareholder value.” Ping An has since trimmed its stake modestly (FACT — SCMP; Bloomberg, May 2024). The episode is now dormant but remains a live governance/geopolitical flag: the register’s largest voice is a Chinese insurer whose interests are not perfectly aligned with minority holders’.

Verdict — good discipline on returns and pruning, but the two biggest recent decisions are a warning, not a validation. HSBC allocates capital better than its history and better than most global universal banks: heavy, policy-anchored distributions, ~17% of shares retired, a clean high-price exit from Canada, and a sensible Western retreat under a restructuring delivering ahead of plan. But two things temper the credit. First, the buyback’s value-accretion is spent — at ~1.8x tangible book HSBC is no longer the sub-book compounding machine the bull case implicitly assumes. Second, and more telling, the $13.7bn Hang Seng privatisation deployed capital at a premium into Hong Kong’s worst-performing loan book while pausing shareholder returns — a control-and-cleanup deal that sits awkwardly against the disciplined-allocator story. Management is competent and shareholder-aware; it is not obviously value-maximising at today’s prices.

8. Changes and Headwinds — Last Two Years

The last two years reshaped HSBC more than any period since the post-2011 “pivot to Asia,” and the direction is coherent — but it has layered execution, geopolitical and rate-cycle headwinds onto a stock that has already re-rated to the richest price-to-book in its own history.

The defining change: a new CEO and the largest restructuring in a decade. Georges Elhedery became Group CEO in September 2024 (from CFO) and in October 2024 unveiled a sweeping simplification: collapsing the old three-segment matrix (WPB/CMB/GBM) into four businesses — Hong Kong, UK, Corporate & Institutional Banking, and International Wealth & Premier Banking — overlaid on an “Eastern markets” (Asia-Pacific + Middle East) / “Western markets” (UK, Europe, Americas) geographic split (theglobaltreasurer, Oct 2024; fintechnews.sg). The programme targets roughly $1.5bn of annualised cost savings by end-2026 against ~$1.8bn of one-off implementation cost, collapses management layers, and scales back the sub-scale Western investment bank (M&A and equity capital markets in the Americas/Europe are being wound down) to concentrate capital on Asia and the Gulf. (Fact.) Elhedery has been explicit that the East-West structure is “not a precursor… to any split” — a direct rebuttal to break-up pressure (finews.asia).

The disposal programme — pruning the Western footprint. HSBC has run a multi-year exit from sub-scale non-Asian retail: Canada retail sold to RBC (~$10bn, closed March 2024, funding a special dividend in FY24); Argentina (Banco Galicia, 2024); exit from US mass-market retail; the France retained home-loan portfolio sale completed in 2025 (crystallising a $1.5bn reserve-recycling loss); the UK life-insurance business sold (completing by Q1-26, a $0.2bn FX-recycling loss); a Malta strategic review with the unit moved to held-for-sale in Q1-26 (a $0.3bn loss); and, most recently, the Turkey unit reportedly in talks to be sold to Emirates NBD (Bloomberg, 30 Jun 2026). This is disciplined capital reallocation — selling low-return, capital-consuming Western retail to double down on the higher-return Asia/wealth core — but it produces recurring disposal losses that depress reported earnings and complicate the run-rate (SEC 20-F FY2025). (Interpretation.)

The governance overhang: Ping An. HSBC’s largest shareholder, China’s Ping An (~8-9% economic), has publicly pushed HSBC to separately list / spin off the Asia business. A special resolution to that effect was defeated at the 2023 AGM (>80% voted with the Board), and management maintains the reorganisation is not a stalking-horse for a break-up — but the pressure is a standing geopolitical/governance overhang and a reminder that HSBC’s register and its strategy sit on the US-China fault line (SCMP; HSBC news archive).

Geopolitics — the structural headwind that never resolves. With ~50%+ of group profit from Asia and the Hong Kong business unit alone contributing 28.2% of group PBT, HSBC is uniquely exposed to US-China tension, the Hong Kong national-security-law regime, tariff escalation, and secondary-sanctions risk — a bank domiciled and regulated in the UK but earning the majority of its profit in Greater China. This is not a two-year change but it has intensified over the period. (Fact on profit mix; interpretation on trajectory.)

The rate cycle turns. The 2023-25 earnings were flattered by higher rates; with the BoE, Fed and (through the HKD peg) HKMA now easing, banking NII is guided merely to hold (>=$45bn in 2026), and NIM/spread income becomes a fading rather than a growing driver — 2025’s 17.2% ex-notable RoTE may be closer to a cyclical high than a structural floor.

Recent live items (Jun-Jul 2026). Four smaller developments frame the current tape: a ~$400m exposure to ailing UAE consumer-goods group IFFCO, where HSBC is the top creditor to a ~$2bn restructuring (Bloomberg, 12 Jun 2026) — a single-name credit blemish; an A$35m Australian Federal Court penalty for scam-protection failings (Jun 2026) — conduct tail; the Google Cloud multi-year AI partnership (Jun 2026) — a cost/efficiency positive; and a deliberate retreat from riskier private-credit fund lending, with HSBC declining to renew facilities that did not clear its return hurdle (Jul 2026) — evidence of the new risk discipline.

Verdict: the changes strengthen the business thesis but not the investment thesis. The cost-out, the Asia/wealth concentration, and the pruning of sub-scale Western retail are exactly what a returns-focused universal bank should do, and Elhedery has executed quickly. But the same period intensified the geopolitical concentration, turned the rate tailwind into a headwind, and — critically — the stock has already re-rated to ~1.8x tangible book (P/B 99th percentile of its own history), so the improvement is largely priced. On balance the franchise is better run and better focused; the margin of safety is gone.

9. Risk Analysis (Risk Matrix)

The single dominant risk is #1 — geopolitical and China-Hong Kong concentration. HSBC earns the majority of its profit in Greater China (the Hong Kong business unit alone is 28.2% of group PBT, and Asia geographically is ~50%+), yet is domiciled and prudentially regulated in the UK. That places it structurally between Washington and Beijing: it must comply with US and UK sanctions regimes while its profit pool and its largest shareholder (Ping An) sit inside China. Any sharp deterioration — a sanctions cut-off, a forced choice on Hong Kong operations, tariff escalation, or a national-security-law clash — is the one risk that could impair the franchise rather than merely dent a year’s earnings. It is not diversifiable within the current strategy; the whole strategic pivot increases it. (Fact on the mix; interpretation on severity.)

Second is #2, rate-cut/NIM compression. The 2023-25 RoTE was rate-flattered. With banking NII guided only to hold at >=$45bn into 2026 and central banks easing, the highest-return element of recent earnings is fading. If the market is capitalising 2025’s 17.2% ex-notable RoTE as structural when it is partly a rate-cycle peak, both earnings and the ~1.8x-TBV multiple (risk #4) are exposed — and those two risks are linked: a RoTE reversion is precisely what would de-rate the richest-ever price-to-book.

Third is credit — #3 and #6. The Hong Kong commercial-real-estate book is deteriorating: the FY2025 ECL charge there rose seven-fold to $0.7bn as secured collateral values fell and impaired exposures climbed to $8.9bn; the mainland-China CRE book, though shrinking (allowance down to $1.0bn), remains a live sore. On top of the systematic CRE stress, the financing book periodically throws off idiosyncratic single-name losses — the ~$400m IFFCO exposure and the $400m UK financial-sponsor fraud are the current examples. Group ECL of $3.9bn (39bps) is manageable today, but the CRE and single-name channels are where a benign credit picture could turn.

The balance sheet itself is a genuine mitigant against a solvency catastrophe — CET1 of 14.9% is comfortably inside the 14-14.5% target range, and liquidity is ample — so the realistic downside is an earnings-and-multiple compression driven by geopolitics, rates and credit, not a wipeout. But on a $3.2tn globally-systemic balance sheet concentrated in the one geopolitical fault line that matters most, the tail (#12) cannot be dismissed. (Interpretation, grounded in the CET1 and profit-mix facts.)

10. Valuation Discussion (Embedded Expectations)

Enterprise-value multiples are meaningless for HSBC — deposits are funding, not leverage, and aggregator “EV” for HSBC is nonsensical (ROIC shows negative EV in 2021–22). The correct lens for a bank is price-to-tangible-book versus return-on-tangible-equity, cross-checked with P/E and total capital-return yield.

Where the stock actually trades — and a load-bearing reconciliation. HSBC’s own reported tangible net asset value per ordinary share at 31-Dec-2025 was ~$9.6 (FY24 $8.61; FY23 $8.19) — a figure that correctly strips out the ~$20bn of AT1 (“other equity instruments”) that belongs to AT1 holders, not ordinary shareholders. Grossed to the ADR (×5), TNAV is ~$48/ADR, so at $99.09 the ADR trades at ~2.05x tangible book (Fact — HSBC FY2025 results). This is materially richer than the ~1.8x implied by third-party aggregators (ROIC’s ~$54/ADR tangible-equity figure includes AT1 in the numerator and understates the multiple); the bank-correct, ordinary-shareholder P/TBV is ~2.05x, and reported RoTE of 13.3% on an average tangible-equity base of ~$160bn confirms the ex-AT1 denominator. On its own multi-year history this is the richest price-to-book ever (valuation-percentile data: P/B 99.1st percentile, P/S 99.9th percentile — both all-time extremes; composite 92.8th) (Fact). On earnings the ADR is ~15.5x FY2025 reported EPS ($6.39; AZI P/E 79.5th percentile) — but only ~12.6x on an ex-notables basis (FY2025 notable items cut PBT by ~$6.7bn: a $2.1bn Bank of Communications impairment, $1.5bn of reserve-recycling losses, $1.4bn of legal provisions, and $1.0bn of restructuring), the number management steers to (Interpretation).

Peer cross-check — HSBC is priced as a premium Asia bank, above its truest Asia peer.

(Sources: company FY2025 results; public P/TBV data. FACT with aggregator caveat.) The table frames the central tension. HSBC’s ~2.05x sits above the UK-only names (Lloyds ~1.4x, Barclays ~1.27x) and — most tellingly — at nearly twice Standard Chartered’s ~1.1x, even though StanChart shares HSBC’s Asia weighting and posted a higher reported RoTE (14.7% vs 13.3%). HSBC trades below DBS (~2.67x on 16.2% ROE) and JPMorgan (~2.9x on ~17–18%). The premium to StanChart is defensible on franchise grounds — HSBC’s Hong Kong deposit base is stickier and larger, its CET1 (14.9%) and payout are heavier, its beta lower, and the market plainly assigns more credence to HSBC’s 17% ambition — but it is a rich relative premium that assumes those advantages persist.

Embedded-expectations analysis — what ~2.05x requires. Using the Gordon relation justified P/TBV = (RoTE − g) / (CoE − g) and HSBC’s lower-beta cost of equity (~9–10%, below Barclays’ ~11% given the 0.84 beta and deposit-funded Asia franchise), back-solving ~2.0x at CoE 9.5% and g 4% implies a durable RoTE of ~15% — i.e., the market prices reported RoTE settling between the 13.3% reported and 17.2% ex-notables levels and holding there permanently, at a low cost of equity. That is a full price: it credits management’s simplification and Asia earnings power as achieved and durable and gives little away.

(Assumptions explicit; illustrative embedded-expectations grid, not a price target. TNAV/ord grows ~4–5%/yr, so two-year-forward implied values scale ~8–10% higher.) The bear case is a re-rating toward ~1.3x if notable items prove semi-recurring and rate cuts plus a China/HK slowdown drag RoTE to ~12%; the base case (~15% durable RoTE at ~9.5% CoE) sits essentially at today’s price; the bull case requires the 17% ambition to be proven clean and permanent and the cost of equity to compress as return durability is demonstrated — two things, not one.

Valuation support — the capital-return floor. The ~2.05x multiple is cushioned by a genuine cash return: the ordinary dividend of $0.75/ordinary ($3.75/ADR, +14% y/y) yields ~3.8%, and adding the ~$6bn of FY2025 buybacks lifts the total capital-return yield to ~5.6% on the ~$336bn market cap, underpinned by a fortress 14.9% CET1 (Fact). This is real, and it compounds TNAV/share — but note that, exactly as with Barclays, buyback accretion fades now that the stock trades at ~2x tangible book (repurchases above TNAV are dilutive to TNAV/share), so the buyback is increasingly a return-of-cash mechanism, not a value-creation lever.

What the market is underwriting correctly vs. incorrectly. Correctly: the balance-sheet strength (CET1 14.9%), the durability of the Hong Kong deposit-funded structural margin, and management’s demonstrated cost/simplification delivery. Potentially incorrectly: (i) treating the 17.2% ex-notables RoTE as a clean run-rate when “notable items” — BoCom impairments, restructuring, legal, reserve recycling — have recurred for years; (ii) paying ~2x Standard Chartered’s multiple for a similar Asia footprint at a lower reported RoTE; and (iii) underpricing HSBC’s rate-cut sensitivity (banking NII is the swing variable as the BoE/HKMA/Fed ease) and its China/HK geopolitical tail. This section sets no price target; it locates the price on the RoTE/CoE grid and hands the judgment to Claude’s Take.

11. Variant Perception

Consensus (mid-2026). The prevailing view is that HSBC is a fixed, de-risked, Asia-anchored compounder finally being paid for its returns. Sentiment has flipped from a decade of “dead-money, over-complex, geopolitically-trapped conglomerate” to belief in the Elhedery simplification story: a 17.2% ex-notables RoTE, a raised 17%+ ambition through 2028, a 14.9% CET1, ~$19bn of annual capital returns, and a stock that has ~doubled in eighteen months back to its 2007 peak. The market treats the re-rating from ~0.6x to ~2.05x tangible book as earned.

The strongest bull case. The franchise’s core advantage — a vast, low-cost, sticky Hong Kong/Asia deposit base — is a genuine, hard-to-replicate structural-margin engine, and management is finally monetising it: the “Eastern/Western” reorganisation is stripping ~$1.5bn of cost, non-core exits (Canada, US retail, France, Argentina, Turkey) are freeing capital, and the 17% RoTE target is being raised, not missed. Capital returns of ~5.6%/yr on a 14.9% CET1 are self-funding and durable, and HSBC still trades below DBS and JPMorgan on P/TBV despite comparable Asia/scale characteristics — leaving room to close the gap if the 17% ambition proves permanent. The tape agrees: +66% trailing-year return (Sharpe 2.35), +44%/yr over three years (Sharpe 1.73), positive alpha, price above all moving averages.

The strongest bear case. This is a re-rated, richly-priced, rate-and-China-levered bank at the top of its multi-decade range, being credited for an adjusted return it has not printed on a reported basis. The 17.2% ex-notables RoTE flatters over a ~$6.7bn PBT drag from items — BoCom impairments, restructuring, legal, reserve recycling — that have recurred often enough to be arguably semi-permanent; reported RoTE was 13.3%. At ~2.05x tangible book (richest-ever, P/B 99th percentile) and ~2x Standard Chartered’s multiple despite StanChart’s higher reported RoTE, the margin of safety of the sub-book era is gone. The swing risks are external: banking NII fades as the BoE/HKMA/Fed cut; ~50%+ of profit is Hong Kong/Asia, exposing HSBC to a China property/growth shock and to US-China/HK national-security-law crossfire; the Ping An breakup overhang and the frictions of operating between two blocs never fully clear. The lifetime record is the warning label — a −74.5% maximum drawdown and a +5.8%/yr lifetime return (Sharpe 0.14) capture what this franchise did to shareholders across 2007–2020.

The 3–5 assumptions that matter most. (1) Durable RoTE — is the through-cycle level the ~17% ex-notables ambition, the ~13–14% reported, or something that sags to ~12% as rates fall and notables recur? This is the whole debate. (2) Are “notable items” one-off or recurring? — the gap between the two RoTE numbers is the valuation. (3) China/Hong Kong — benign Asian growth and a stable HK deposit franchise vs. a property/geopolitical shock to ~50% of profit. (4) Rate path — how much of the margin is structural vs. a rate-cycle peak. (5) Cost of equity — does the market hold HSBC’s low ~9–10% CoE, or re-widen a China-risk premium?

Falsification tests. The bull case fails if: reported RoTE prints below ~12% for consecutive quarters as rate cuts and fresh “notable” impairments bite; or a China/HK credit or geopolitical shock forces a capital-return pause; or the ex-notables/reported RoTE gap fails to narrow, exposing the 17% figure as chronically adjusted. The bear case fails if: HSBC sustains reported RoTE ≥14–15% through a full easing cycle (proving the returns are structural, not a rate/hedge peak), notable items genuinely fade, and the CoE compresses toward DBS/JPMorgan levels — which would justify holding ~2.05x+ tangible book.

Factor-positioning fold-in (positioning read). HSBC’s factor DNA (FactorsToday, All-Factors model, r²=0.60) is not a classic style-Momentum crowd: the significant loadings are Country: United Kingdom +0.65 (dominant), Market +0.52 (overall beta 0.84), USDollar −0.44 (it behaves like a non-US/EM-tilted asset — it gains when the dollar weakens), CreditRisk +0.42, Materials/Mining +0.40/+0.25 and Hong Kong +0.06 (an Asia/commodity/EM-cyclical tilt), and DividendYield +0.29; the pure style factors are near-zero (Value −0.07, Quality +0.06) (Fact). So the correct framing is not “crowded momentum trade” and not “falling knife” — it is a low-beta, high-dividend, UK-and-weak-dollar-and-credit-and-Asia-macro compounder that has been spectacularly in favour for three years and now sits at the top of its multi-decade range, back at its 2007 all-time high, with no cushion below the high. The variant-perception question is therefore not whether the business improved — it plainly did — but whether consensus, having flipped from a decade of skepticism to belief after a double, has now priced the 17% ambition as clean-and-permanent and become anchored to a benign USD/credit/China regime. The empirical tells (richest-ever P/B, a ~2x premium to a higher-RoTE Asia peer, reported RoTE well below the headline ambition, buyback accretion fading, and the −0.44 USDollar / +0.42 CreditRisk loadings that would punish a dollar spike or spread-widening) suggest the risk/reward has shifted from the deeply-skewed-up setup of the 0.6x-book era to roughly balanced-to-full today.

12. Fact vs. Interpretation

13. Open Questions

1. What is the true through-cycle RoTE? The gap between reported 13.3% and ex-notables 17.2% is the entire valuation debate. Do “notable items” fade to near-zero under a simplified group, or do disposal/associate/legal/restructuring charges keep recurring at $3–7bn a year?
2. How rate-sensitive is the earnings base, precisely? HSBC gives banking-NII guidance but not a clean, disclosed NII-per-25bps sensitivity across the HKD-peg, GBP and USD books. How much of the 17% ex-notables RoTE survives a full Fed/HKMA/BoE easing cycle?
3. Hang Seng asset quality. With Hang Seng now wholly owned, its 6.7% NPL ratio and ~36% HK-CRE loan concentration consolidate fully into HSBC. What is the residual ECL runway on the Hong Kong CRE book, and where does it peak?
4. Ping An’s intentions. Is the spin-off campaign genuinely dormant, or does it re-emerge if the share price stalls or geopolitics deteriorate? What is Ping An’s current stake and voting posture?
5. When does the buyback resume, and at what size? Buybacks paused for the Hang Seng deal; management will decide quarterly. Does the pace return to ~$2bn/quarter, and does management acknowledge diminishing TNAV-accretion above 2x book?
6. Geopolitical tail. What is HSBC’s contingency if forced to choose sides in a US-China sanctions escalation touching Hong Kong operations? This is unquantifiable but existential.

14. What Must Be True (Bull and Bear, with Falsification Tests)

For the BULL case (HSBC compounds from here and holds/expands ~2x tangible book):

• HSBC must sustain reported RoTE of ~14–15%+ through a full rate-easing cycle, proving the returns are structural (Asia wealth + transaction banking), not a NIM/hedge peak.
• Notable items must genuinely fade, narrowing the reported-vs-ex-notables gap so the 17% ambition is delivered clean.
• China/Hong Kong must stay benign — a stable HK deposit franchise, a bottoming CRE cycle, no sanctions/geopolitical rupture — and the cost of equity must compress toward DBS/JPMorgan levels.
• Falsification test: reported RoTE prints below ~12% for consecutive quarters as rate cuts and fresh impairments bite; or a China/HK credit or geopolitical shock forces a capital-return pause; or the ex-notables/reported gap fails to narrow over 2026–27.

For the BEAR case (HSBC de-rates from a richest-ever multiple toward its higher-RoTE Asia peer):

• The market must be capitalising a rate-peak, add-back-inflated 17% RoTE as clean-and-permanent at a compressed cost of equity, leaving no margin of safety at ~2.05x TBV.
• Rate cuts must compress banking NII, notable items must persist, and the ~2x premium to Standard Chartered (which earns a higher reported RoTE at ~1.1x) must prove unjustified.
• Falsification test: HSBC sustains reported RoTE ≥14–15% through the easing cycle, notable items fade, credit stays benign, and the CoE compresses — which would validate ~2.05x+ tangible book and break the bear case.

The bull and bear share one hinge: whether 2025–26’s returns are a structural achievement or a cyclical peak dressed in an adjusted number. Every falsification test above is a variant of that single question.

APPENDIX A — Standard Diligence Questionnaire

HSBC Holdings plc (NYSE: HSBC). Answers grounded in the analysis above; Fact/Interpretation labels where material. As-of 2026-07-10.

General

What thoughtful questions have other investors asked about this company? The perennial ones: (1) Should HSBC be broken up — spin off or separately list the Asia business (Ping An’s campaign)? (2) Is HSBC an Asian bank or a Western one, and which regulator/geopolitical bloc ultimately controls its fate? (3) Is the mid-teens RoTE structural or a rate-cycle peak? (4) Why does it trade below DBS/JPMorgan but above Standard Chartered on P/TBV? (5) Are the recurring “notable items” one-offs or a permanent tax of running a global conglomerate? This memo treats (3) and (5) as the crux.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Nearer a high. FY2025 ex-notables RoTE (17.2%) and Q1-26 (18.7% annualised) are ~20-year records, materially rate-flattered (banking NII ~$44bn, HIBOR ~2.5% via the HKD-Fed peg, structural-hedge reinvestment). As the Fed/HKMA/BoE ease, the NII tailwind fades. (Interpretation.) Driven by external environment or internal actions? Both — internal (cost-out, disposals, buybacks, Hang Seng consolidation) and external (rate cycle, Asia reopening). The internal actions are genuine; the rate tailwind is borrowed. How stable are revenues? Barbell: ~two-thirds NII (stable, rate-sensitive, deposit-funded) + ~one-third fees, of which wealth (+24%) and transaction banking are high-quality/recurring and markets/IB is cyclical. Outlook for products/services; how big is the market? Growing in the areas that matter — Asian/Gulf wealth (secular household-wealth tailwind), cross-border trade/transaction banking (#1 globally). Shrinking deliberately in Western retail/IB. International, Asia-weighted.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Split: Hong Kong/Asia banking is a stable, regulated oligopoly (3 note-issuing banks); global transaction banking consolidates around a few networks (favourable); UK retail is a shared, stable oligopoly; global markets/IB is intensely competitive and US-dominated (HSBC subscale — exiting). How profitable is the business (ROIC/ROE)? Reported RoTE 13.3% / ex-notables 17.2% (FY25); ROE (total-equity) ~13%. Good for a universal bank; through-cycle probably low-teens. Barriers to entry? Very high in HK (licence + note issuance + deposits + 160-yr incumbency) and in the global trade network (irreplicable correspondent web); moderate/shared in UK retail; low in markets/IB. Can the business be easily understood? No — a $3.2tn, ~58-market conglomerate with a persistent reported-vs-adjusted gap and geopolitical entanglement. Complexity is a permanent analytical tax. Undermined by foreign low-cost labour? Not directly relevant; the threat is fintech/payments disintermediation and geopolitics, not labour arbitrage. Do brands matter? Nature of competition? Switching costs? The HSBC/Hang Seng brands carry real trust equity in HK/Asia. Corporate-treasury switching costs (integrated cash management, multi-country credit) are high; retail current-account switching is low but sticky.

Financial Condition & Balance Sheet

Assets not fully recognised on the balance sheet? The global transaction-banking network and HK deposit franchise are intangible franchise value not on the books. Off-balance-sheet liabilities? Standard banking off-balance-sheet (guarantees, commitments, derivatives); disclosed. Conservatism of accounting? IFRS 9 ECL is judgment-heavy; HSBC took precautionary Middle East ($300m) and idiosyncratic fraud ($400m) charges in Q1-26 — reasonably conservative. Watch HK/China-CRE provisioning. CapEx-hungry? Not physically; it is capital-hungry in the regulatory sense (CET1, RWAs) — the Hang Seng deal consumed 120bps of CET1.

Capital Allocation & Management

How much FCF; how is it used; philosophy? Bank “FCF” ≈ distributable earnings after CET1 maintenance. Philosophy: ~50% dividend payout + buybacks + high-hurdle inorganic; ~$19bn/yr returned. Significant acquisitions? Hang Seng minority privatisation ($13.7bn, 2026) — the notable one, read as defensive control/cleanup. Buying back shares? Yes — ~17% of ordinary shares retired 2021–25; but above ~2x TBV the accretion is spent. Issuing shares to insiders? Normal LTI/scheme grants (~35m conditional shares 2026); no unusual dilution. Compensation policy/motivations? Well-aligned scorecards (Group RoTE 25% of bonus; LTI RoTE 42.5% + relative TSR 42.5%, CET1 underpin); forward targets undisclosed. CEO Elhedery single-figure ~£5.4m.

Valuation & Market Data

ADR, MLP, or K-1? ADR (1 ADS = 5 ordinary shares); not an MLP/K-1. Dividends generally qualified; UK/HK withholding considerations apply to holders. Dividend policy? ~50% payout ex-material-notables; FY25 $0.75/ord ($3.75/ADR), ~3.8% yield; quarterly. How profitable? See above. Net income vs cash from operations diverging? Bank CFO is dominated by working-capital/deposit swings and is not a clean quality signal; anchor on RoTE and CET1 generation, not CFO.

Risks & Downside

What would cause the stock to decline? RoTE reverting toward ~12% as rates fall; recurring notable items; HK/China CRE credit deterioration; a US-China/HK geopolitical or sanctions shock; a forced buyback pause; multiple de-rating from richest-ever P/B. Risk of catastrophic loss? Low-probability but non-trivial given ~50%+ profit concentration in Greater China and $3.2tn systemic balance sheet — a sanctions rupture or HK systemic event is the existential tail. Chance of total loss? Very low near-term — CET1 14.9%, deep deposit funding — but the −74.5% lifetime max drawdown is the warning label.

Recent News & Events

Has the business environment changed recently? Yes — new CEO (Sep-24) + largest reorg in a decade; rate cycle turning from tailwind to headwind. Significant acquisitions/disposals? Hang Seng privatisation (buy); Canada/Argentina/US-retail/France/Indonesia/Malta/Turkey (sells). Change in accounting policies? None material beyond ongoing IFRS 9/17. Recent changes — new markets/facilities/management? Google Cloud AI partnership (Jun-26); private-credit retreat (Jul-26); A$35m Australia fine (Jun-26); ~$400m IFFCO exposure (Jun-26). Direction: shrink Western, double-down Eastern/wealth.

APPENDIX B — Source Appendix

HSBC Holdings plc (NYSE: HSBC) — Source Appendix

Primary sources first. HSBC is a UK-incorporated foreign private issuer; it files Form 20-F (annual) and Form 6-K (interim) with the SEC, and reports in USD under IFRS. 1 ADS = 5 ordinary shares. Prices as of 2026-07-10 unless noted.

Primary — company filings & disclosures

• HSBC Holdings plc — Annual Results 2025 media release (25-Feb-2026): reported PBT $29.9bn, revenue $68.3bn, reported RoTE 13.3% / ex-notables 17.2%, CET1 14.9%, TNAV/ordinary ~$9.6, dividend $0.75/ord, $6bn buyback, 2026–28 targets (RoTE 17%+ ex-notables, ~50% payout, ~1% cost growth, revenue growth to ~5% by 2028). https://www.hsbc.com/investors/results-and-announcements/all-reporting/annual-results-2025-quick-read
• HSBC Holdings plc — Form 20-F FY2025 (SEC, CIK 0001089113): audited financial statements, segment disclosure, risk factors, capital, ECL. https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001089113&type=20-F
• HSBC — Q1-2026 earnings release & analyst call transcript (5-May-2026): Q1-26 RoTE ex-notables 18.7% annualised; banking-NII guide ~$46bn; ECL guide ~45bps; CET1 14.0%; wealth NNM $39bn ($34bn Asia); $400m UK financial-sponsor fraud + $300m Middle East ECL; Hang Seng privatisation completed. (ROIC.ai get_latest_earnings_call.)
• HSBC — FY2024 Annual Report & 20-F; Directors’ Remuneration Report/Policy Supplement 2025 (incentive metrics: annual bonus 60% financial [Group RoTE 25%], LTI RoTE 42.5% / relative TSR 42.5%). https://www.hsbc.com/-/files/hsbc/investors/hsbc-results/2025/annual/pdfs/hsbc-holdings-plc/260225-directors-remuneration-policy-supplement.pdf
• HSBC — SEC 6-K own-share transaction notices (share-count reduction 20.6bn→17.14bn ordinary, 2021–2025).
• HSBC — Hang Seng Bank privatisation press release (9-Oct-2025; completed 26-Jan-2026): $13.7bn, 33% premium, ~120bps CET1. https://www.hsbc.com/news-and-views/news/media-releases/2025/hsbc-proposes-to-privatise-hang-seng-bank-by-scheme-of-arrangement
• HSBC — HSBC Canada sale to RBC completion RNS (28-Mar-2024): ~$10bn, $4.8bn gain, +0.7pp CET1, $0.21 special dividend.
• Company results (peer P/TBV & RoTE cross-checks): Standard Chartered, Lloyds, Barclays, DBS Group, JPMorgan FY2025 results.

Primary — quantitative data services

• ROIC.ai MCP — income statement, balance sheet, per-share, profitability ratios, valuation multiples (accessed 2026-07-10). Note: aggregator “tangible book” (~$54/ADR) does not deduct ~$20bn AT1; HSBC’s own TNAV (~$48/ADR) governs. EV meaningless/negative for a deposit-funded bank.
• Market price & valuation-percentile data (2026-07-09/10): ADR $99.09; P/B 99.1st pctile (1.72x on aggregator book), P/S 99.9th, P/E 79.5th, composite 92.8th of own ~10y history.
• FactorsToday factor model (2026-07-09/10): beta 0.84, trailing-12m return +66% (Sharpe 2.35), lifetime max drawdown −74.5%; loadings Country-UK +0.65, USDollar −0.44, CreditRisk +0.42, DividendYield +0.29. Related/peer stocks: LYG, BCS, SCBFY, PUK.

Secondary — industry & press

• Euromoney — Trade Finance Survey 2025 (HSBC #1 trade-finance bank, 8th consecutive year); World’s Best Bank for Large Corporates 2025.
• Hong Kong Monetary Authority (HKMA) — note-issuing bank status; HKD peg mechanics.
• Bloomberg / Financial Times / Reuters — Emirates NBD/Turkey talks (30-Jun-2026); IFFCO ~$400m exposure (12-Jun-2026); private-credit retreat (7-Jul-2026); Australia A$35m AUSTRAC fine (Jun-2026); Google Cloud AI partnership (Jun-2026); CEO pay (19-Feb-2025).
• Fortune — HSBC Argentina exit / $1bn loss (9-Apr-2024).
• South China Morning Post — Ping An spin-off campaign; 2023 AGM defeat.
• finews.asia / hubbis / wealthbriefing — Asia wealth franchise, NNIA, notable-items detail.
• Public company filings and results for peer banks (Barclays, Standard Chartered, Lloyds, DBS, JPMorgan) used for cross-read.

All non-obvious facts in the memo are cited inline with source and date. Management commentary (guidance, targets) is treated as hypothesis and validated against filings and external data; where reported and adjusted figures diverge, both are shown and the reported figure governs the verdict.